Tropomyosin Receptor Kinases Inhibitors
DBCAT005471Pharmacologic class
A DrugBank category of 1 drug. 1 of them is approved.
- Drugs
What you can answer from here — as of June 02, 2021
Which targets do Tropomyosin Receptor Kinases Inhibitors share, and which companies have late-stage candidates in this class?
Create a free account or log in to explore the full data card.
Create Account